Gangnam-gu Pharmaceutical Chapter announced to proceed with debate regarding the efficacy of Ursa, even if Daewoong absent
On Mar 13, Gangnam-gu Pharmaceutical Chapter sent an official document to Daewoong Pharmaceutical related to a debate regarding the efficacy of Ursa (UDCA), and requested to attend the debate. It was told that Gangnam-gu Pharmaceutical Chapter plans to proceed with debate even if they absent.
It...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
